Strata Critical Medical Inc Warrants
SRTAW
SRTAW was delisted on the 6th of May, 2026.
0 hedge funds and large institutions have $0 invested in Strata Critical Medical Inc Warrants in 2026 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, reducing their positions, and 8 closing their positions.
15.91% less ownership
Funds ownership: 15.91% → 0% (-16%)
100% less funds holding
Funds holding: 8 → 0 (-8)
100% less capital invested
Capital invested by funds: $11.3K → $0 (-$11.3K)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 8
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
LP
LMR Partners
London,
United Kingdom
|
-$9.41K |
| 2 |
VF
Virtu Financial
New York
|
-$1K |
| 3 |
WAM
Wolverine Asset Management
Chicago,
Illinois
|
-$731 |
| 4 |
SCM
Saba Capital Management
New York
|
-$183 |
| 5 |
CS
Clear Street
New York
|
-$1 |
SRTAW Hedge Fund Activity: Q2 2026 in Review
0 of the 8,344 institutional investors tracked by Wall St. Rank reported a position in Strata Critical Medical Inc Warrants (SRTAW) for Q2 2026, worth a combined $0 — down 100% from $11.3K a quarter earlier.
Sellers outnumbered buyers: 8 funds closed out of SRTAW and 0 opened new positions — a net loss of 8 holders — while 0 trimmed existing stakes and 0 added.
The largest seller was LMR Partners, exiting entirely with an estimated $9.41K sold.
- 0 institutional investors held Strata Critical Medical Inc Warrants (SRTAW) as of Q2 2026, down from 8 in Q1 2026.
- Funds reported $0 of Strata Critical Medical Inc Warrants stock for Q2 2026, down 100% quarter-over-quarter.
- 0 funds opened new Strata Critical Medical Inc Warrants positions in Q2 2026 and 8 closed out, a net change of -8 holders.
- The largest Strata Critical Medical Inc Warrants seller in Q2 2026 was LMR Partners, an estimated $9.41K sold.
Based on aggregated 13F filings for Q2 2026.